Verastem reported $-16962000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Curis CRIS:US $ -16.11M 2.49M
Cytokinetics CYTK:US $ -86.75M 56.18M
Epizyme EPZM:US $ -55.47M 4.84M
Immunogen IMGN:US $ -24.14M 13.03M
Laboratory Of America LH:US $ 749.3M 114.4M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Verastem VSTM:US $ -16.96M 0.48M
YTE INCY:US $ 172.84M 1.75M
Ziopharm Oncology ZIOP:US $ -9.79M 2M